Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Medistim Earnings Release 2014

Aug 20, 2014

3662_rns_2014-08-20_8ea11701-9e1a-4514-872c-3341384f7b92.html

Earnings Release

Open in viewer

Opens in your device viewer

Results for the second quarter and the first half 2014 for Medistim ASA

Results for the second quarter and the first half 2014 for Medistim ASA

Sales ended at MNOK 47.9 for the quarter (MNOK 49.0).

Sales for the 1st half increased by 2.3 % and ended

at MNOK 96.7 (MNOK 94.5). There was a positive

development in USA with 41 % increase in sales in the

2nd quarter and 9.1 % for the first half. The

reduction in total sales for the quarter is related

to delayed system sales in Europe. Operating profit

(EBIT) for the quarter ended at MNOK 11.7 (MNOK

12.8). Operating profit for the 1st half ended at

MNOK 18.9 (MNOK 20.1). There was paid a dividend of

MNOK 14.5 in the second quarter 2014, NOK 0.80 per

share (NOK 1.10 per share).